Skip to main content
Erschienen in: Allergo Journal 4/2020

15.06.2020 | Telemedizin | Titel Zur Zeit gratis

Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c

Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H

verfasst von: Prof. Dr. med. Ludger Klimek, Prof. Dr. med. Oliver Pfaar, Prof. Dr. med. Margitta Worm, Thomas Eiwegger, Dr. med. Jan Hagemann, Prof. Dr. med. Markus Ollert, MD, PhD Eva Untersmayr, Dr. med. Karin Hoffmann-Sommergruber, Alessandra Vultaggio, Ioana Agache, Sevim Bavbek, Apostolos Bossios, Ingrid Casper, Susan Chan, Alexia Chatzipetrou, Prof. Dr. med. Christian Vogelberg, Davide Firinu, Paula Kauppi, Antonios Kolios, Akash Kothari, Andrea Matucci, Dr. med. Oscar Palomares, Zsolt Szépfalusi, Wolfgang Pohl, Wolfram Hötzenecker, Alexander Rosenkranz, Prof. Dr. med. Karl-Christian Bergmann, Prof. Dr. Dr. med. Thomas Bieber, Roland Buhl, Prof. Dr. med. Jeroen Buters, Prof. Dr. med. Ulf Darsow, Thomas Keil, Prof. Dr. med. Jörg Kleine-Tebbe, Prof. Dr. med. Susanne Lau, Prof. Dr. med. Marcus Maurer, Hans Merk, Prof. Dr. med. dDpl.-Ing. Ralph Mösges, Prof. Dr. med. Joachim Saloga, Petra Staubach, Prof. Dr. med. Uta Jappe, Claus Rabe, Dr. med. Uta Rabe, Prof. Dr. med. Claus Vogelmeier, Prof. Dr. med. Tilo Biedermann, Priv.-Doz. Dr. med. Kirsten Jung, Wolfgang Schlenter, Prof. Dr. med. Dr. phil. Johannes Ring, Adam Chaker, Prof. Dr. med. Wolfgang Wehrmann, PD Dr. med. Sven Becker, Laura Freudelsperger, Norbert Mülleneisen, Katja Nemat, Prof. Dr. med. Wolfgang Czech, Holger Wrede, Prof. Dr. med. Randolf Brehler, Prof. Dr. med. Thomas Fuchs, Peter-Valentin Tomazic, Prof. Dr. med. Werner Aberer, Antje Fink Wagner, Fritz Horak, PD Mag. Dr. Stefan Wöhrl, Verena Niederberger-Leppin, Isabella Pali-Schöll, Regina Roller-Wirnsberger, Otto Spranger, Dr. med. Rudolf Valenta, Mübecell Akdis, Paolo M. Matricardi, François Spertini, Nikolai Khaltaev, Jean-Pierre Michel, Larent Nicod, Prof. Dr. med. Peter Schmid-Grendelmeier, Marco Idzko, Prof. Dr. med. Eckard Hamelmann, Prof. Dr. med. Thilo Jakob, Prof. Dr. med. Thomas Werfel, Priv.-Doz. Dr. med. Martin Wagenmann, Prof. Dr. med. Christian Taube, Prof. Dr. med. Erika Jensen-Jarolim, Stephanie Korn, Francois Hentges, Jürgen Schwarze, Liam O´Mahony, Edward Knol, Stefano del Giacco, Tomás Chivato, Jean Bousquet, Prof. Dr. med. Torsten Zuberbier, Cezmi Akdis, Marek Jutel

Erschienen in: Allergo Journal | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Auszug

a Überarbeitete, aktualisierte und inhaltlich auf die Situation in Deutschland, Österreich, der Schweiz und Luxemburg adaptierte Fassung des EAACI-Positionspapiers: Vultaggio et al. Considerations on Biologicals for Patients with allergic disease in times of the COVID-2 19 pandemic: an EAACI Statement. Allergy (submitted). bDie ersten fünf Autoren sind gemeinsame Erstautoren. cDie letzten vier Autoren sind gemeinsame Letztautoren. …
Literatur
1.
Zurück zum Zitat Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-44 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-44
2.
Zurück zum Zitat Li Q, Guan X, Wu P, Wang X, Zhou L, Tonget Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382:1199-207 Li Q, Guan X, Wu P, Wang X, Zhou L, Tonget Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382:1199-207
3.
Zurück zum Zitat Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20 Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20
4.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506
5.
Zurück zum Zitat Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39 Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39
6.
Zurück zum Zitat Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol. 2004;1:119-22 Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol. 2004;1:119-22
7.
Zurück zum Zitat Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23 Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23
8.
Zurück zum Zitat Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; https://doi.org/10.1111/all.14238 Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; https://​doi.​org/​10.​1111/​all.​14238
9.
Zurück zum Zitat Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.
10.
Zurück zum Zitat WHO. World Health Organization. www.who.int. Published 2020. Accessed 26.05.2020 WHO. World Health Organization. www.who.int. Published 2020. Accessed 26.05.2020
11.
Zurück zum Zitat Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol. 2011;1:226-32 Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol. 2011;1:226-32
12.
Zurück zum Zitat Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016;10;19:181-93 Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016;10;19:181-93
13.
Zurück zum Zitat Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26:453-5 Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26:453-5
14.
Zurück zum Zitat Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020; https://doi.org/10.1093/cid/ciaa310 Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020; https://​doi.​org/​10.​1093/​cid/​ciaa310
15.
Zurück zum Zitat To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20:565-74 To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20:565-74
16.
Zurück zum Zitat Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020; https://doi.org/10.1111/pai.13271 Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020; https://​doi.​org/​10.​1111/​pai.​13271
17.
Zurück zum Zitat Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271-280.e278. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271-280.e278.
18.
Zurück zum Zitat Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;S0091-6749(20)30495-4; https://doi.org/10.1016/j.jaci.2020.04.006 Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;S0091-6749(20)30495-4; https://​doi.​org/​10.​1016/​j.​jaci.​2020.​04.​006
19.
Zurück zum Zitat Lagunas-Rangel FA, Chávez-Valencia V. High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. J Med Virol 2020; https://doi.org/10.1002/jmv.25900 Lagunas-Rangel FA, Chávez-Valencia V. High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. J Med Virol 2020; https://​doi.​org/​10.​1002/​jmv.​25900
20.
Zurück zum Zitat Arnaldez FI, O'Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, et al. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer 2020;8:e000930 Arnaldez FI, O'Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, et al. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer 2020;8:e000930
21.
Zurück zum Zitat Cunningham L, Kimber I, Basketter DA, McFadden JP. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection. Autoimmun Rev. 2020;102563; https:doi.org/10.1016/j.autrev.2020.102563 Cunningham L, Kimber I, Basketter DA, McFadden JP. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection. Autoimmun Rev. 2020;102563; https:doi.org/10.1016/j.autrev.2020.102563
22.
Zurück zum Zitat Sabogal Pineros YS, Bal SM, Dijkhuis A, Majoor CJ, Dierdorp BS, Dekkeret T, et al. Eosinophils capture viruses, a capacity that is defective in asthma. Allergy. 2019;74:1898-909 Sabogal Pineros YS, Bal SM, Dijkhuis A, Majoor CJ, Dierdorp BS, Dekkeret T, et al. Eosinophils capture viruses, a capacity that is defective in asthma. Allergy. 2019;74:1898-909
23.
Zurück zum Zitat Jackson DJ, Busse WW, Bacharier LB, Kattan M, O'Connor GT, Wood RA, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;22:S0091-6749(20)30551-0 Jackson DJ, Busse WW, Bacharier LB, Kattan M, O'Connor GT, Wood RA, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;22:S0091-6749(20)30551-0
24.
Zurück zum Zitat Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination. J Allergy Clin Immunol. 2020;25:S0091-6749(20)30569-8 Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination. J Allergy Clin Immunol. 2020;25:S0091-6749(20)30569-8
25.
Zurück zum Zitat Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382:2012-22 Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382:2012-22
26.
Zurück zum Zitat Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yanet YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020; https://doi.org/10.1111/all.14289 Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yanet YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020; https://​doi.​org/​10.​1111/​all.​14289
27.
Zurück zum Zitat Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020; https://doi.org/10.1093/cid/ciaa272 Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020; https://​doi.​org/​10.​1093/​cid/​ciaa272
28.
Zurück zum Zitat Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl International. 2020;117:271-8 Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Dtsch Arztebl International. 2020;117:271-8
29.
Zurück zum Zitat Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Jama. 2020;323:1574-81 Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Jama. 2020;323:1574-81
30.
Zurück zum Zitat Agache I, Akdis CA. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019;130:1493-503 Agache I, Akdis CA. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019;130:1493-503
31.
Zurück zum Zitat Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy. 2015;70:727-54 Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy. 2015;70:727-54
32.
Zurück zum Zitat Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, et al. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy. 2019;74:2293-311 Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, et al. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy. 2019;74:2293-311
33.
Zurück zum Zitat Palomares O, Untersmayr E, Gutermuth J, Agache I, Ajeganova S, Bavbek S, et al. Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy. 2020;75:936-40 Palomares O, Untersmayr E, Gutermuth J, Agache I, Ajeganova S, Bavbek S, et al. Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019. Allergy. 2020;75:936-40
34.
Zurück zum Zitat Pfaller B, Yepes-Nunez JJ, Agache I, Akdis CA, Alsalamah M, Bavbek S, et al. Biologicals in atopic disease in pregnancy: an EAACI position paper. Allergy. 2020; https://doi.org/10.1111/all.14282 Pfaller B, Yepes-Nunez JJ, Agache I, Akdis CA, Alsalamah M, Bavbek S, et al. Biologicals in atopic disease in pregnancy: an EAACI position paper. Allergy. 2020; https://​doi.​org/​10.​1111/​all.​14282
35.
Zurück zum Zitat Eyerich S, Metz M, Bossios A, Eyerich K. New biological treatments for asthma and skin allergies. Allergy. 2020;75:546-60 Eyerich S, Metz M, Bossios A, Eyerich K. New biological treatments for asthma and skin allergies. Allergy. 2020;75:546-60
36.
Zurück zum Zitat Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393-414 Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393-414
37.
Zurück zum Zitat Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74: 2312-9 Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74: 2312-9
38.
Zurück zum Zitat Jonstam K, Swanson BN, Mannent LP, Cardell LO, Tian N, Wang Y, et al. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy. 2019;74:743-52 Jonstam K, Swanson BN, Mannent LP, Cardell LO, Tian N, Wang Y, et al. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy. 2019;74:743-52
39.
Zurück zum Zitat Hassani M, Koenderman L. Immunological and hematological effects of IL-5(Ralpha)-targeted therapy: An overview. Allergy. 2018;73:1979-88 Hassani M, Koenderman L. Immunological and hematological effects of IL-5(Ralpha)-targeted therapy: An overview. Allergy. 2018;73:1979-88
40.
Zurück zum Zitat Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364:1005-15 Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364:1005-15
41.
Zurück zum Zitat Edwards MR, Strong K, Cameron A, Walton RP, Jackson DJ, Johnston SL. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J Allergy Clin Immunol. 2017;140:909-20 Edwards MR, Strong K, Cameron A, Walton RP, Jackson DJ, Johnston SL. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J Allergy Clin Immunol. 2017;140:909-20
42.
Zurück zum Zitat Jartti T, Smits HH, Bonnelykke K, Bircan O, Elenius V, Konradsen JR, et al. Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy. 2019;74:40-52 Jartti T, Smits HH, Bonnelykke K, Bircan O, Elenius V, Konradsen JR, et al. Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy. 2019;74:40-52
43.
Zurück zum Zitat Maizels RM, William CG. How helminths go viral. Science 2014;345:517-8 Maizels RM, William CG. How helminths go viral. Science 2014;345:517-8
44.
Zurück zum Zitat Rogers KJ, Brunton B, Mallinger L, Bohan D, Sevcik KM, Chen J, et al. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection. PLoS Negl Trop Dis. 2019;13:e0007819. Rogers KJ, Brunton B, Mallinger L, Bohan D, Sevcik KM, Chen J, et al. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection. PLoS Negl Trop Dis. 2019;13:e0007819.
45.
Zurück zum Zitat Lee A, Park SP, Park CH, Kang BH, Park SH, Ha SJ, et al. IL-4 Induced Innate CD8+ T Cells Control Persistent Viral Infection. PLoS Pathog. 2015;11:e1005193 Lee A, Park SP, Park CH, Kang BH, Park SH, Ha SJ, et al. IL-4 Induced Innate CD8+ T Cells Control Persistent Viral Infection. PLoS Pathog. 2015;11:e1005193
46.
Zurück zum Zitat Lin S-J, Shu P-Y, Chang C, Ng A-K, Hu C-p. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol. 2003;171:4708-16 Lin S-J, Shu P-Y, Chang C, Ng A-K, Hu C-p. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol. 2003;171:4708-16
47.
Zurück zum Zitat Portales-Cervantes L, Crump OM, Dada S, Liwski CR, Gotovina J, Haidl ID, et al. IL-4 enhances interferon production by virus-infected human mast cells. J Allergy Clin Immunol. 2020;S0091-6749(20)30264-5 Portales-Cervantes L, Crump OM, Dada S, Liwski CR, Gotovina J, Haidl ID, et al. IL-4 enhances interferon production by virus-infected human mast cells. J Allergy Clin Immunol. 2020;S0091-6749(20)30264-5
48.
Zurück zum Zitat Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ Jr, Calatroni A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476-85 Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ Jr, Calatroni A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476-85
49.
Zurück zum Zitat Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, et al. No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy. J Eur Acad Dermatol Venereol. 2020; https://doi.org/10.1111/jdv.16552 Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, et al. No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy. J Eur Acad Dermatol Venereol. 2020; https://​doi.​org/​10.​1111/​jdv.​16552
50.
Zurück zum Zitat Karamloo F, König R. SARS-CoV-2 immunogenicity at the crossroads. Allergy. 2020; https://doi.org/10.1111/all.14360 Karamloo F, König R. SARS-CoV-2 immunogenicity at the crossroads. Allergy. 2020; https://​doi.​org/​10.​1111/​all.​14360
51.
Zurück zum Zitat Agache I, Song Y, Rocha C, Beltran J, Posso M, Steiner C, et al. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy. 2020;75:1058-68 Agache I, Song Y, Rocha C, Beltran J, Posso M, Steiner C, et al. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy. 2020;75:1058-68
52.
Zurück zum Zitat Agache I, Rocha C, Beltran J, Song Y, Posso M, Solà I, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma. Allergy. 2020;75:1043-57 Agache I, Rocha C, Beltran J, Song Y, Posso M, Solà I, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma. Allergy. 2020;75:1043-57
53.
Zurück zum Zitat Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. Allergy. 2020;75:1023-42 Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. Allergy. 2020;75:1023-42
54.
Zurück zum Zitat Klimek L, Forster-Ruhrmann U, Becker S, Chaker A, Huppertz T, Deitmer T, et al. Stellungnahme zur Anwendung von Glukokortikosteroiden bei entzündlichen Erkrankungen der oberen Atemwege (u. a. Allergische Rhinitis/chronische Rhinosinusitis) während der aktuellen COVID-19-Pandemie - Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA), des Deutschen Berufsverbandes der HNO-Ärzte (BVHNO) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC). Laryngorhinootologie. 2020;99:280-1 Klimek L, Forster-Ruhrmann U, Becker S, Chaker A, Huppertz T, Deitmer T, et al. Stellungnahme zur Anwendung von Glukokortikosteroiden bei entzündlichen Erkrankungen der oberen Atemwege (u. a. Allergische Rhinitis/chronische Rhinosinusitis) während der aktuellen COVID-19-Pandemie - Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA), des Deutschen Berufsverbandes der HNO-Ärzte (BVHNO) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC). Laryngorhinootologie. 2020;99:280-1
55.
Zurück zum Zitat Agache I, Lau S, Akdis CA, Smolinska S, Bonini M, Cavkaytar O, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019;74:855-73 Agache I, Lau S, Akdis CA, Smolinska S, Bonini M, Cavkaytar O, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019;74:855-73
56.
Zurück zum Zitat Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, et al. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie 2017;71(12):e3 Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, et al. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie 2017;71(12):e3
57.
Zurück zum Zitat Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799-815 Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799-815
58.
Zurück zum Zitat Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73:765-98 Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73:765-98
59.
Zurück zum Zitat Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73:744-64 Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73:744-64
60.
Zurück zum Zitat de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46-55 de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46-55
61.
Zurück zum Zitat Romanelli A, Mascolo S. Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis. Am J Transplant. 2020; https://doi.org/10.1111/ajt.15905 Romanelli A, Mascolo S. Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis. Am J Transplant. 2020; https://​doi.​org/​10.​1111/​ajt.​15905
62.
Zurück zum Zitat Rudnicka L, Goldust M, Glowacka P, Sikora M, Sar-Pomian M, Rakowska A, et al. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern. J Am Acad Dermatol. 2020. https://doi.org/10.1016/j.jaad.2020.04.153 Rudnicka L, Goldust M, Glowacka P, Sikora M, Sar-Pomian M, Rakowska A, et al. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern. J Am Acad Dermatol. 2020. https://​doi.​org/​10.​1016/​j.​jaad.​2020.​04.​153
63.
Zurück zum Zitat Tian L, Liu W, Sun L. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors]. Sheng Wu Gong Cheng Xue Bao. 2020;36:605-11 Tian L, Liu W, Sun L. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors]. Sheng Wu Gong Cheng Xue Bao. 2020;36:605-11
64.
Zurück zum Zitat Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports. J Eur Acad Dermatol Venereol. 2020; https://doi.org/10.1111/jdv.16527 Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports. J Eur Acad Dermatol Venereol. 2020; https://​doi.​org/​10.​1111/​jdv.​16527
65.
Zurück zum Zitat Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;1-12; https://doi.org/10.1038/s41577-020-0311-8 Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;1-12; https://​doi.​org/​10.​1038/​s41577-020-0311-8
Metadaten
Titel
Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c
Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H
verfasst von
Prof. Dr. med. Ludger Klimek
Prof. Dr. med. Oliver Pfaar
Prof. Dr. med. Margitta Worm
Thomas Eiwegger
Dr. med. Jan Hagemann
Prof. Dr. med. Markus Ollert
MD, PhD Eva Untersmayr
Dr. med. Karin Hoffmann-Sommergruber
Alessandra Vultaggio
Ioana Agache
Sevim Bavbek
Apostolos Bossios
Ingrid Casper
Susan Chan
Alexia Chatzipetrou
Prof. Dr. med. Christian Vogelberg
Davide Firinu
Paula Kauppi
Antonios Kolios
Akash Kothari
Andrea Matucci
Dr. med. Oscar Palomares
Zsolt Szépfalusi
Wolfgang Pohl
Wolfram Hötzenecker
Alexander Rosenkranz
Prof. Dr. med. Karl-Christian Bergmann
Prof. Dr. Dr. med. Thomas Bieber
Roland Buhl
Prof. Dr. med. Jeroen Buters
Prof. Dr. med. Ulf Darsow
Thomas Keil
Prof. Dr. med. Jörg Kleine-Tebbe
Prof. Dr. med. Susanne Lau
Prof. Dr. med. Marcus Maurer
Hans Merk
Prof. Dr. med. dDpl.-Ing. Ralph Mösges
Prof. Dr. med. Joachim Saloga
Petra Staubach
Prof. Dr. med. Uta Jappe
Claus Rabe
Dr. med. Uta Rabe
Prof. Dr. med. Claus Vogelmeier
Prof. Dr. med. Tilo Biedermann
Priv.-Doz. Dr. med. Kirsten Jung
Wolfgang Schlenter
Prof. Dr. med. Dr. phil. Johannes Ring
Adam Chaker
Prof. Dr. med. Wolfgang Wehrmann
PD Dr. med. Sven Becker
Laura Freudelsperger
Norbert Mülleneisen
Katja Nemat
Prof. Dr. med. Wolfgang Czech
Holger Wrede
Prof. Dr. med. Randolf Brehler
Prof. Dr. med. Thomas Fuchs
Peter-Valentin Tomazic
Prof. Dr. med. Werner Aberer
Antje Fink Wagner
Fritz Horak
PD Mag. Dr. Stefan Wöhrl
Verena Niederberger-Leppin
Isabella Pali-Schöll
Regina Roller-Wirnsberger
Otto Spranger
Dr. med. Rudolf Valenta
Mübecell Akdis
Paolo M. Matricardi
François Spertini
Nikolai Khaltaev
Jean-Pierre Michel
Larent Nicod
Prof. Dr. med. Peter Schmid-Grendelmeier
Marco Idzko
Prof. Dr. med. Eckard Hamelmann
Prof. Dr. med. Thilo Jakob
Prof. Dr. med. Thomas Werfel
Priv.-Doz. Dr. med. Martin Wagenmann
Prof. Dr. med. Christian Taube
Prof. Dr. med. Erika Jensen-Jarolim
Stephanie Korn
Francois Hentges
Jürgen Schwarze
Liam O´Mahony
Edward Knol
Stefano del Giacco
Tomás Chivato
Jean Bousquet
Prof. Dr. med. Torsten Zuberbier
Cezmi Akdis
Marek Jutel
Publikationsdatum
15.06.2020
Verlag
Springer Medizin
Erschienen in
Allergo Journal / Ausgabe 4/2020
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-020-2553-y

Weitere Artikel der Ausgabe 4/2020

Allergo Journal 4/2020 Zur Ausgabe

AeDA/DGAKI informieren

Fotoallergische Reaktionen

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.